Taiwan FDA registration b0cd86ffaebd8ef1984f239ff1ac629b
Reashan progesterone detection reagent
TW: 禮亞尚黃體酮檢測試劑
Taiwan·Risk Class 2·DIASORIN INC.;;DIASORIN S.P.A.·Registered Nov 04, 2009 – Nov 04, 2019CancelledRegistration details
- Analysis ID
- b0cd86ffaebd8ef1984f239ff1ac629b
- Customs Code
- DHA00602040501
Company information
- Manufacturer
- DIASORIN INC.;;DIASORIN S.P.A.
- Manufacturer Country
- Italy;;United States
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- The Progesterone Assay uses direct competition chemistry cold light immunoassay (CLIA) technology to quantify progesterone in human serum or plasma samples. This assay is intended for in vitro diagnostic use.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Grade Material (Analysis Material Non-Analysis);; A.1620 黃體脂酮試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Nov 04, 2009
- Expiry Date
- Nov 04, 2019
- Cancellation Date
- May 19, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Reashan progesterone detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b0cd86ffaebd8ef1984f239ff1ac629b and manufactured by DIASORIN INC.;;DIASORIN S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices